theory clinical_55_3
imports Main


begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  PathogenicMutation :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  BindingPartner :: "entity ⇒ bool"
  Localises :: "event ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  SitesOfDNADamage :: "entity ⇒ bool"
  Links :: "event ⇒ bool"
  BRCA1 :: "event ⇒ bool"
  HRRepair :: "event ⇒ bool"
  DNA :: "event ⇒ bool"
  Promotes :: "event ⇒ bool"
  Joining :: "entity ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  HomologousRepairMolecules :: "entity ⇒ bool"
  RAD51Homolog1 :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"

(* Explanation 1: Patient with a pathogenic mutation in PALB2 *)
axiomatization where
  explanation_1: "∃x y. Patient x ∧ PathogenicMutation y ∧ In x y ∧ PALB2 y"

(* Explanation 2: PALB2 encodes a binding partner that localises BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage *)
axiomatization where
  explanation_2: "∀x y z e. PALB2 x ∧ BindingPartner y ∧ Localises e ∧ BRCA2 z ∧ SitesOfDNADamage z ∧ Links e ∧ BRCA1 e ∧ BRCA2 z ∧ HRRepair e ∧ DNA e"

(* Explanation 3: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)
axiomatization where
  explanation_3: "∀x y z e. BRCA2 x ∧ Promotes e ∧ Joining y ∧ Undamaged y ∧ HomologousRepairMolecules y ∧ RAD51Homolog1 z ∧ Humans z"


theorem hypothesis:
 assumes asm: "Loss e ∧ PALB2 x ∧ BRCA2 y"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
 shows "∃e x y. Loss e ∧ PALB2 x ∧ BRCA2 y ∧ Action e ∧ Prevents e ∧ Agent e x ∧ Patient e y ∧ Joining e ∧ RepairMolecules e ∧ Undamaged e ∧ HRR e"
  sledgehammer
  oops

end
